GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dermapharm Holding DMP.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

38.35

+0.92%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

11 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 6Buy
  • 3Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 38.35Average target 43.25

Low
34.34
Average
43.25
Median
44.88
High
50.40

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue€1.20bn€1.25bn€1.30bn€1.35bn€1.46bn
Revenue, highest€1.23bn€1.27bn€1.31bn€1.37bn€1.52bn
Revenue, lowest€1.19bn€1.24bn€1.28bn€1.33bn€1.42bn
Earnings per share2.623.013.263.40—
Earnings per share, highest2.783.393.693.48—
Earnings per share, lowest2.432.712.943.35—
Analysts66522

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026
Forecast0.470.41
Reported0.460.72
Difference-1.5%+75.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 11.7% a year over 10 years. Return on equity 19.1%.

Model fair value

42.92

From earnings 42.92, from revenue 37.99.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.